MARKET-OVERVIEW
OVERVIEW
Our products will initially target the point-of-care (POC) and physician’s office laboratory (POL) market segments within the domestic and international in vitro diagnostics device market, with expansion predicted into retail pharmacy/over-the-counter (OTC), clinical labs, and Health Care Associations. Our customers will include physicians, hospitals, emergency rooms, wholesale distributors, and pharmacies.
Market Strategy
Our products have been designed to offer a clear-cut differentiation with currently available tests for monitoring diabetes, kidney function and coagulation.
-
Lower cost
-
User convenience
-
Value of information
-
Facilitation of doctor-patient feedback
-
Therapeutic intervention